Glossary
| Acronym | Definition | ||
|---|---|---|---|
| AMR | Antimicrobial Resistance | ||
| ARV | Antiretroviral | ||
| BARDA | Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services |
||
| CDC | Centers for Disease Control and Prevention | ||
| EH&S | Environmental Health and Safety | ||
| EMA | European Medicines Agency | ||
| ESG | Environmental, Social and Governance | ||
| EUA | Emergency Use Authorization | ||
| FDA | U.S. Food and Drug Administration | ||
| GPH | Global Public Health | ||
| JJBC | Johnson & Johnson Bioethics Committee | ||
| JJMDC | Johnson & Johnson Medical Devices Companies | ||
| JLABS | Johnson & Johnson Innovation—JLABS | ||
| LMICs | Low- and middle-income countries | ||
| MDR-TB | Multidrug-resistant tuberculosis | ||
| OCMO | The Johnson & Johnson Office of the Chief Medical Officer | ||
| OCMS | Office of Consumer Medical Safety | ||
| PTA | Priority Topics Assessment | ||
| RSV | Respiratory syncytial virus | ||
| RWD | Real-world data | ||
| RWE | Real-world evidence | ||
| SDG | Sustainable Development Goal (of the United Nations) | ||
| STH | Soil Transmitted Helminths (or intestinal parasites) | ||
| USAID | U.S. Agency for International Development | ||
| WHO | World Health Organization |
